<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25084811</article-id>
      <article-id pub-id-type="pmc">4124474</article-id>
      <article-id pub-id-type="publisher-id">1756-0500-7-487</article-id>
      <article-id pub-id-type="doi">10.1186/1756-0500-7-487</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Silent polymorphisms in the <italic>RYR1</italic> gene do not modify the phenotype of the p.4898 I&gt;T pathogenic mutation in central core disease: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Cuperman</surname>
            <given-names>Thais</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>thacuperman@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Fernandes</surname>
            <given-names>Stephanie A</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>stephanieaf@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Louren&#xE7;o</surname>
            <given-names>Naila CV</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>lourenconcv@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Yamamoto</surname>
            <given-names>Lydia U</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>lydiauy@usp.br</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Silva</surname>
            <given-names>Helga CA</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>halsilva@uol.com.br</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Pavanello</surname>
            <given-names>Rita CM</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>rpavanello@ib.usp.br</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Yamamoto</surname>
            <given-names>Guilherme L</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>glyamamoto@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Zatz</surname>
            <given-names>Mayana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mayazatz@usp.br</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Oliveira</surname>
            <given-names>Acary SB</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>dircee@neuro.epm.br</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A10">
          <name>
            <surname>Vainzof</surname>
            <given-names>Mariz</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mvainzof@usp.br</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Laboratory of Muscle Proteins and Comparative Histopathology, Human Genome Research Center, Biosciences Institute, University of S&#xE3;o Paulo, R. do Mat&#xE3;o, 106 &#x2013; Cidade Universit&#xE1;ria, S&#xE3;o Paulo, SP CEP 05508-900, Brazil</aff>
      <aff id="I2"><label>2</label>Department of Neurology and Neurosurgery, Division of Neuromuscular Disorders, Federal University of S&#xE3;o Paulo (Unifesp), S&#xE3;o Paulo SP, Brazil</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <volume>7</volume>
      <fpage>487</fpage>
      <lpage>487</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Cuperman et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Cuperman et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Central core disease is a congenital myopathy, characterized by presence of central core-like areas in muscle fibers. Patients have mild or moderate weakness, hypotonia and motor developmental delay. The disease is caused by mutations in the human ryanodine receptor gene (<italic>RYR1</italic>), which encodes a calcium-release channel. Since the <italic>RYR1</italic> gene is huge, containing 106 exons, mutation screening has been limited to three &#x2018;hot spots&#x2019;, with particular attention to the C-terminal region. Recent next- generation sequencing methods are now identifying multiple numbers of variants in patients, in which interpretation and phenotype prevision is difficult.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>In a Brazilian Caucasian family, clinical, histopathological and molecular analysis identified a new case of central core disease in a 48-year female. Sanger sequencing of the C-terminal region of the <italic>RYR1</italic> gene identified two different missense mutations: c.14256 A &gt;&#x2009;C polymorphism in exon 98 and c.14693&#xA0;T &gt;&#x2009;C in exon 102, which have already been described as pathogenic. Trans-position of the 2 mutations was confirmed because patient&#x2019;s daughter, mother and sister carried only the exon 98&#x2019;s mutation, a synonymous variant that was subsequently found in the frequency of 013&#x2013;0,05 of alleles. Further next generation sequencing study of the whole <italic>RYR1</italic> gene in the patient revealed the presence of additional 5 common silent polymorphisms in homozygosis and 8 polymorphisms in heterozygosis.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Considering that patient&#x2019;s relatives showed no pathologic phenotype, and the phenotype presented by the patient is within the range observed in other central core disease patients with the same mutation, it was concluded that the c.14256 A &gt;&#x2009;C polymorphism alone is not responsible for disease, and the associated additional silent polymorphisms are not acting as modifiers of the primary pathogenic mutation in the affected patient. The case described above illustrates the present reality where new methods for wide genome screening are becoming more accessible and able to identify a great variety of mutations and polymorphisms of unknown function in patients and their families.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Congenital myopathies</kwd>
        <kwd>Central core disease</kwd>
        <kwd>Ryanodin receptor 1 gene (<italic>RYR1</italic>)</kwd>
        <kwd>Modifying effect</kwd>
        <kwd>Genotype/phenotype correlations</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Core myopathies is a group of clinically and genetically heterogeneous congenital myopathies with focally reduced oxidative activity visualized on muscle biopsy as their common defining histopathological feature [<xref ref-type="bibr" rid="B1">1</xref>]. These areas, defined as <italic>cores,</italic> can be single or multiple, central or eccentric and run through a large area by longitudinal muscle fiber axis visualized on muscle biopsy [<xref ref-type="bibr" rid="B2">2</xref>]. The wide range of described terms applied to these disorders (central cores, minicores, multicores, multi-minicores) is due to variability of oxidative stain irregularities seen in the histopathological analysis [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Central core disease (CCD, Online Mendelian Inheritance of Man #117000) is characterized by the presence of a central and single core-like area on oxidative stains [<xref ref-type="bibr" rid="B3">3</xref>]. It indicates areas of sarcomeric disorganization and electron microscopy displays mitochondrial depletion and variable degrees of degeneration of the contractile apparatus. Abnormal expression of several sarcomeric and intermediate filament proteins can be seen by immunohistochemical studies [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>CCD is intimately linked to malignant hyperthermia susceptibility (MHS, Online Mendelian Inheritance of Man #145600) [<xref ref-type="bibr" rid="B7">7</xref>], a skeletal muscle&#x2019;s pharmacogenetic disorder that is triggered by administration of inhalational anesthetics and depolarizing muscle relaxants in susceptible individuals [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Both conditions have been associated to mutations in human <italic>RYR1</italic> gene (Online Mendelian Inheritance of Man #180901), located on chromosome 19q13.1. It is a large gene organized in 106 exons [<xref ref-type="bibr" rid="B9">9</xref>] that encodes a calcium (Ca<sup>2+</sup>) release channel known as the ryanodine receptor (<italic>RYR1</italic>) situated on skeletal muscle. The ryanodine receptor is a huge protein of 5037 amino acids [<xref ref-type="bibr" rid="B10">10</xref>] constituted of four <italic>RYR1</italic> 560&#xA0;kDa peptides and many associated proteins with a total molecular weight of more than 2,500&#xA0;kDa.</p>
      <p>Currently, more than 200 mutations in <italic>RYR1</italic> gene have been described. Some are exclusively associated with CCD or other <italic>RYR1</italic>-related myopathies; others are related with malignant hyperthermia susceptibility trait, or even with both conditions concomitantly [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>The <italic>RYR1</italic> mutational spectrum linked with CCD includes mostly heterozygous dominant missense variants and minor deletions or duplications [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. <italic>RYR1</italic> mutations associated with malignant hyperthermia (MH) and CCD are grouped in three regions of <italic>RYR1</italic> protein or &#x2018;hot spots&#x2019;: N-terminal (residues p.M1-R614), central (p.R2163&#x2013;p.R2458) and C-terminal (p.R4136-p.P4973). These regions are also entitled domains 1&#x2013;3, respectively [<xref ref-type="bibr" rid="B14">14</xref>]. Domains 1 and 2 are situated in soluble cytoplasmic regions of the protein. Domain 3 is placed in C-terminus and involves the transmembrane/luminal and pore-forming area of the channel. It is also where most of CCD mutations are located [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. Variable genotype&#x2013;phenotype correlations associated with mutations in <italic>RYR1</italic> gene are usually justified by the degree of functional variation within this large protein [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Here we present clinical features of a family diagnosed with central core myopathy, in which the affected index case, in addition to the causative mutation in the <italic>RYR1</italic> gene, also presented several other polymorphisms in this gene, which apparently are not acting as modifiers of the primary pathogenic mutation.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>The index case, a 48-year-old Caucasian female, was referred to our service with a history of muscle weakness since childhood. Her delivery and peri-natal period were uneventful. She was a hypotonic baby, had delayed milestones and presented congenital dislocation of the hip as a child. Her present clinical evaluation consisted of mild facial and proximal muscle weakness, lumbar lordosis and scoliosis. She had no cardiac abnormalities and no respiratory complaints. An electromyography exam done in her childhood showed a myopathic pattern. Serum creatine kinase activity (CK) was normal.A muscle biopsy of biceps brachii was performed under local anesthesia. Histological analysis of hematoxilin/eosin (H&amp;E) staining revealed variation in fiber size, split fibers, some fibers with membrane debris in its interior and presence of multiple nuclei within the majority of fibers. Myofibrillar ATPase reaction showed a predominance of type I fibers, and NADH-adenine dinucleotide-tetrazolium reductase reaction revealed areas devoid of oxidative activity (cores) in almost all fibers (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). Normal localization and distribution was found for all studied muscle proteins: dystrophin, the 4 sarcoglycan, dysferlin, calpain 3, telethonin, and &#x3B1;2-laminin, excluding several forms of limb-girdle muscular dystrophies.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>The pedigree of the family, and mutations identified in each member of the family, and respective eletroferogram of part of exon 102 and exon 98 of the </bold><bold><italic>RYR1 </italic></bold><bold>gene illustrating the missense alterations.</bold> Histological reactions showing HE, ATPase 4.3 and NADH staining, and immunohistochemical analysis for dystrophin, &#x3B3;-SG and telethonin. (Magnification &#x2013; X200).</p>
        </caption>
        <graphic xlink:href="1756-0500-7-487-1"/>
      </fig>
      <p>For molecular analysis, Sanger sequencing for the C-terminal region (exons 94 to 106) of the <italic>RYR1</italic> gene was first done in genomic DNA, extracted from peripheral blood lymphocytes [<xref ref-type="bibr" rid="B16">16</xref>], using PCR amplification with described primers [<xref ref-type="bibr" rid="B17">17</xref>]. Sequencing was done using sequencing kit (Applied Biosystems&#xAE;) on an ABI 3730 automated DNA sequencer (Life Technologies).</p>
      <p>Subsequently, next generation sequencing of the whole <italic>RYR1</italic> gene was done using Illumina&#x2019;s Nextera kits for library preparation and custom capture of 88 genes involved in neuromuscular disorders. Sequencing was performed at the Illumina MiSeq sequencer, and variants were filtered and compared to the control populations of 1000 Genomes, NIH, and 6500 Exome Sequencing Project from Washington University.</p>
      <p>Molecular analysis of the <italic>RYR1</italic> gene showed two different mutations in the patient (II-2): a missense mutation c.14256 A &gt;&#x2009;C in exon 98, leading to a silencing alteration p.4752&#xA0;T &gt;&#x2009;T, and a pathogenic missense mutation c.14693&#xA0;T &gt;&#x2009;C in exon 102, which results in the p.4898 I &gt;&#x2009;T substitution in the protein. The c.14256 A &gt;&#x2009;C mutation was also identified in her daughter (III-1). To exclude a possible unknown deleterious potential, we studied the mother (I-2) and sister (II-1) of the index case, and the same alteration was found in both: in a homozygous state in the mother, and heterozygous state in the sister (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). None of the relatives presented the pathogenic mutation in exon 102. Additional next generation sequencing study of the whole <italic>RYR1</italic> gene in the patients revealed, in addition to the c.14693&#xA0;T &gt;&#x2009;C and c.14256 A &gt;&#x2009;C mutations, the presence of 5 common silent polymorphisms in homozygosis and 8 polymorphisms in heterozygosis (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>
            <bold>Variants identified in the </bold>
            <bold>
<italic>RYR1 </italic>
</bold>
            <bold>gene trough NGS sequencing of a panel of 88 muscle genes using MiSeq &#x2013; Ilumina panel</bold>
          </p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="right"/>
            <col align="right"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>AAChange.refGene</bold>
              </th>
              <th align="right">
                <bold>6500 exomes</bold>
              </th>
              <th align="right">
                <bold>1000 genomes</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Homozygouse variants<hr/></td>
              <td align="right" valign="bottom">&#xA0;<hr/></td>
              <td align="right" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon7:c.A594G:p.L198L,RYR1:NM_001042723:exon7:c.A594G:p.L198L<hr/></td>
              <td align="right" valign="bottom">0,603029<hr/></td>
              <td align="right" valign="bottom">0,6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon11:c.T1077C:p.A359A,RYR1:NM_001042723:exon11:c.T1077C:p.A359A<hr/></td>
              <td align="right" valign="bottom">0,895202<hr/></td>
              <td align="right" valign="bottom">0,93<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon15:c.G1668A:p.S556S,RYR1:NM_001042723:exon15:c.G1668A:p.S556S<hr/></td>
              <td align="right" valign="bottom">0,632093<hr/></td>
              <td align="right" valign="bottom">0,64<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon19:c.C2286T:p.P762P,RYR1:NM_001042723:exon19:c.C2286T:p.P762P<hr/></td>
              <td align="right" valign="bottom">0,617023<hr/></td>
              <td align="right" valign="bottom">0,62<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T<hr/></td>
              <td align="right" valign="bottom">0,597092<hr/></td>
              <td align="right" valign="bottom">0,6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Heterozygouse variants<hr/></td>
              <td align="right" valign="bottom">&#xA0;<hr/></td>
              <td align="right" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon45:c.C7260T:p.H2420H,RYR1:NM_001042723:exon45:c.C7260T:p.H2420H<hr/></td>
              <td align="right" valign="bottom">0,02914<hr/></td>
              <td align="right" valign="bottom">0,03<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon49:c.C7872T:p.R2624R,RYR1:NM_001042723:exon49:c.C7872T:p.R2624R<hr/></td>
              <td align="right" valign="bottom">0,168538<hr/></td>
              <td align="right" valign="bottom">0,16<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon50:c.G7977A:p.T2659T,RYR1:NM_001042723:exon50:c.G7977A:p.T2659T<hr/></td>
              <td align="right" valign="bottom">0,319545<hr/></td>
              <td align="right" valign="bottom">0,36<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon51:c.T8118C:p.I2706I,RYR1:NM_001042723:exon51:c.T8118C:p.I2706I<hr/></td>
              <td align="right" valign="bottom">0,319775<hr/></td>
              <td align="right" valign="bottom">0,36<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon51:c.T8190C:p.D2730D,RYR1:NM_001042723:exon51:c.T8190C:p.D2730D<hr/></td>
              <td align="right" valign="bottom">0,32362<hr/></td>
              <td align="right" valign="bottom">0,37<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon53:c.G8337A:p.E2779E,RYR1:NM_001042723:exon53:c.G8337A:p.E2779E<hr/></td>
              <td align="right" valign="bottom">0,308213<hr/></td>
              <td align="right" valign="bottom">0,35<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon55:c.T8589C:p.S2863S,RYR1:NM_001042723:exon55:c.T8589C:p.S2863S<hr/></td>
              <td align="right" valign="bottom">0,313624<hr/></td>
              <td align="right" valign="bottom">0,36<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_000540:exon62:c.A9186G:p.P3062P,RYR1:NM_001042723:exon62:c.A9186G:p.P3062P<hr/></td>
              <td align="right" valign="bottom">0,310857<hr/></td>
              <td align="right" valign="bottom">0,35<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">RYR1:NM_001042723:exon97:c.A14241C:p.T4747T,RYR1:NM_000540:exon98:c.A14256C:p.T4752T<hr/></td>
              <td align="right" valign="bottom">0,108642<hr/></td>
              <td align="right" valign="bottom">0,14<hr/></td>
            </tr>
            <tr>
              <td align="left">RYR1:NM_001042723:exon101:c.T14678C:p.I4893T,RYR1:NM_000540:exon102:c.T14693C:p.I4898T</td>
              <td align="right">0</td>
              <td align="right">0</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>NM_: Accession prefix for RNA and protein products that are mainly derived from GenBank cDNA and EST data and are supported by the RefSeq eukaryotic curation group. <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/refseq/about/">http://www.ncbi.nlm.nih.gov/refseq/about/</ext-link>.</p>
          <p>Frequency in the 6500 exomes and1000 genomes.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Central core myopathy (CCD) is one of the most common described congenital myopathies, yet its prevalence and incidence are still uncertain. A regional study in England demonstrated a frequency for CCD of 1 in 250.000 individuals [<xref ref-type="bibr" rid="B17">17</xref>], while another study in Japan revealed that carrier frequency for heterozygous <italic>RYR1</italic> mutations in that population could be as high as 1 in 2000 [<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <p>Most patients with RYR-related CCD usually have mild or moderate axial and proximal weakness marked in the hip girdle, characterized generally in infancy with hypotonia or in early childhood with motor developmental delay [<xref ref-type="bibr" rid="B3">3</xref>]. Skeletal muscle complications such as congenital developmental hip dysplasia, scoliosis and foot deformities (talipes equinovarus) are quite common, as well as myalgia, muscle stiffness, and exertional weakness with or without rhabdomyolysis are frequently related and may be the only exhibiting features. Bulbar and respiratory muscle involvement is unusual, but has been seen in the most severe neonatal cases, and sporadically in adults. Still, there can be significant variability in gravity and age of onset of CCD and marked phenotype heterogeneity, frequently within the same family, has been documented [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <p>Our patient presented clinical features suggesting a congenital myopathy with a relatively mild progression. Histological analysis confirmed the diagnosis of CCD. Although neither her parents, sister nor daughter presented similar symptoms, a possible late-onset manifestation, or a very mild weakness raised doubt about the genetic counseling in this family. The youngest patient&#x2019;s daughter could have inherited the mutations and was still in her reproductive years.</p>
      <p>The initial molecular analysis encompassing the C-terminal region of the <italic>RYR1</italic> gene revealed two different mutations in the patient; one found in exon 102, which was already described as pathogenic [<xref ref-type="bibr" rid="B10">10</xref>], whereas the mutation in exon 98 has been described as a single nucleotide polymorphism, with allele frequency between 0,87/0,13 and 0,95/0,05, and heterozygosis of 0,22 [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. The c.14693&#xA0;T &gt;&#x2009;C mutation in exon 102 has been first described in a large Mexican affected family [<xref ref-type="bibr" rid="B10">10</xref>]. Twenty-one individuals of 35 members were diagnosed with CCD after clinical evaluation, and symptoms ranged from mild to severe, associating this mutation with a highly variable phenotype of CCD. Affected individuals presented with at least one of the symptoms consistent with CCD: foetal hypotonia, muscular weakness at birth, delayed motor milestones, proximal muscle weakness, foot deformities, scoliosis and congenital hip dislocation [<xref ref-type="bibr" rid="B10">10</xref>]. Subsequently, this same mutation was also described in other populations. It was found in 3 patients from Italian and Swiss-Italian families, with muscle weakness as the main symptom [<xref ref-type="bibr" rid="B24">24</xref>] and in two other families from France and North America, in which both presented muscular weakness and delayed motor milestones [<xref ref-type="bibr" rid="B15">15</xref>]. In Japan, one patient was identified, with very severe clinical condition, including decreased foetal movements, hypotonia, respiratory insufficiency at birth, delayed milestones, congenital dislocation of the hip, scoliosis and facial muscle weakness [<xref ref-type="bibr" rid="B13">13</xref>]. Considering the above clinical descriptions, the c.14693&#xA0;T &gt;&#x2009;C mutation is compatible both with severe and mild phenotypes.</p>
      <p>As our patient is presenting a relatively benign clinical course, probably there is no significant association between her pathogenic mutation and the p.4752&#xA0;T &gt;&#x2009;T synonymous polymorphism, nor with any of the other silencing mutations later identified in her DNA, that could be acting as a modifier of her phenotype, by affecting transcription, splicing, mRNA transport, and translation.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>As our patient&#x2019;s phenotype is within the range of other patients described with the same heterozygous mutation, the associated polymorphisms identified in her DNA apparently are not contributing to worsen her phenotype. Additionally, since all the tested relatives have only the p.4752&#xA0;T &gt;&#x2009;T polymorphism and don&#x2019;t present any typical CCD features, it can be inferred that this variant alone, in a homozygous or heterozygous state is not responsible for the disease.</p>
      <p>The case described above illustrates the present reality where new methods for wide genome screening are becoming more accessible and able to identify a great variety of mutations and polymorphisms in patients and their families. It is still impossible to tell if this information helps making more diagnosis and genotype/phenotype associations, or if it turns the diagnostic process more confusing and complex. It is important to always have this in mind before reaching to a definite diagnosis for patients and involved family.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient, her daughter, mother and sister, for genetic testing and for publication of this Case Report including any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. This study was approved by the Comiss&#xE3;o Nacional de &#xC9;tica em Pesquisa (CONEP - Brazilian ethics committee) &#x2013; University of Sao Paulo and Federal University of Sao Paulo, under the number 297.008.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>CCD: Central core disease; CK: Creatine kinase; H&amp;E: Hematoxilin/eosin; MH: Malignant hyperthermia; NADH: Adenine dinucleotide-tetrazolium reductase; NGS: Next generation sequencing; <italic>RYR1</italic>: Ryanodin receptor gene 1.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>Conception and design: MV, TC, and ASBO. Acquisition of data: TC, SA, NCVL, LUY, HCS, GLY, RCP, Analysis and interpretation of data: TC, MZ, and MV. Involved in drafting the manuscript or revising it critically for important intellectual content: TC, HCS, and MV. Gave final approval of the version to be published: MV and TC. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgments</title>
      <p>The authors would like to thank the following researchers, for scientific and technical support: Marta Canovas, Camila de Freitas Almeida, Priscila Calyjur, Leticia Nogueira. This work was supported by Funda&#xE7;&#xE3;o de Amparo a Pesquisa do Estado de S&#xE3;o Paulo - Centro de Pesquisa, Inova&#xE7;&#xE3;o e Difus&#xE3;o (FAPESP-CEPID), Conselho Nacional de Desenvolvimento Cient&#xED;fico e Tecnol&#xF3;gico (CNPq-INCT), Associa&#xE7;&#xE3;o Brasileira de Distrofia Muscular (ABDIM) and CAPES-COFECUB.</p>
      <sec>
        <title>Web resources</title>
        <p>1000 Genomes [<ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org">http://browser.1000genomes.org</ext-link>].</p>
        <p>dbSNP Short Genetic Variations [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/">http://www.ncbi.nlm.nih.gov/projects/SNP/</ext-link>].</p>
        <p>NHLBI Exome Sequencing Project (ESP) Exome Variant Server.</p>
        <p>[<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>].</p>
        <p>NCBI: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/refseq/about/">http://www.ncbi.nlm.nih.gov/refseq/about/</ext-link>.</p>
      </sec>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jungbluth</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sewry</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Muntoni</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Core myopathies</article-title>
          <source>Semin Pediatr Neurol</source>
          <year>2011</year>
          <volume>18</volume>
          <issue>4</issue>
          <fpage>239</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1016/j.spen.2011.10.005</pub-id>
          <pub-id pub-id-type="pmid">22172419</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sewry</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dwyer</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Dove</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Schroder</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Furst</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Helliwell</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Laing</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Quinlivan</surname>
            <given-names>RC</given-names>
          </name>
          <article-title>The spectrum of pathology in central core disease</article-title>
          <source>Neuromuscul Disord</source>
          <year>2002</year>
          <volume>12</volume>
          <issue>10</issue>
          <fpage>930</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-8966(02)00135-9</pub-id>
          <pub-id pub-id-type="pmid">12467748</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jungbluth</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Muntoni</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ferreiro</surname>
            <given-names>A</given-names>
          </name>
          <article-title>15th ENMC International workshop: core myopathies, 9-11th March 2007, Naarden, The Netherlands</article-title>
          <source>Neuromuscul Disord</source>
          <year>2008</year>
          <volume>8</volume>
          <issue>12</issue>
          <fpage>989</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="pmid">18948004</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sewry</surname>
            <given-names>CA</given-names>
          </name>
          <article-title>The role of immunocytochemistry in congenital myopathies</article-title>
          <source>Neuromuscul Disord</source>
          <year>1998</year>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>394</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-8966(98)00053-4</pub-id>
          <pub-id pub-id-type="pmid">9713857</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Van der Ven</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Jap</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>ter Laak</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Nonaka</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Barth</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Sengers</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Stadhouders</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Ramaekers</surname>
            <given-names>FC</given-names>
          </name>
          <article-title>Immunophenotyping of congenital myopathies: disorganization of sarcomeric, cytoskeletal and extracellular matrix proteins</article-title>
          <source>J Neurol Sci</source>
          <year>1995</year>
          <volume>129</volume>
          <issue>2</issue>
          <fpage>199</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(94)00282-S</pub-id>
          <pub-id pub-id-type="pmid">7608737</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vita</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Migliorato</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Baradello</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mazzeo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rodolico</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Falsaperla</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Messina</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Expression of cytoskeleton proteins in central core disease</article-title>
          <source>J Neurol Sci</source>
          <year>1994</year>
          <volume>124</volume>
          <issue>1</issue>
          <fpage>71</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(94)90013-2</pub-id>
          <pub-id pub-id-type="pmid">7931424</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Denborough</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Dennett</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>RM</given-names>
          </name>
          <article-title>Central-core disease and malignant hyperpyrexia</article-title>
          <source>Br Med J</source>
          <year>1973</year>
          <volume>1</volume>
          <issue>5848</issue>
          <fpage>272</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.1.5848.272</pub-id>
          <pub-id pub-id-type="pmid">4265427</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rueffert</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Olthoff</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Deutrich</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schober</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Froster</surname>
            <given-names>UG</given-names>
          </name>
          <article-title>A new mutation in the skeletal ryanodine receptor gene (<italic>RYR1</italic>) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformation</article-title>
          <source>Am J Med Genet</source>
          <year>2004</year>
          <volume>124</volume>
          <issue>3</issue>
          <fpage>248</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">14708096</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Phillips</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Fujii</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Khanna</surname>
            <given-names>VK</given-names>
          </name>
          <name>
            <surname>DeLeon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yokobata</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>de Jong</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>MacLennan</surname>
            <given-names>DH</given-names>
          </name>
          <article-title>The structural organization of the human skeletal muscle ryanodine receptor (<italic>RYR1</italic>) gene</article-title>
          <source>Genomics</source>
          <year>1996</year>
          <volume>34</volume>
          <issue>1</issue>
          <fpage>24</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1996.0238</pub-id>
          <pub-id pub-id-type="pmid">8661021</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lynch</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lehane</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mallet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Giblin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Heffron</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Vaughan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zafra</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>MacLennan</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>TV</given-names>
          </name>
          <article-title>A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1999</year>
          <volume>96</volume>
          <issue>7</issue>
          <fpage>4164</fpage>
          <lpage>4169</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.96.7.4164</pub-id>
          <pub-id pub-id-type="pmid">10097181</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Davis</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Haan</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Jungbluth</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sewry</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>North</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Muntoni</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kuntzer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lamont</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bankier</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tomlinson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sanchez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Walsh</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nagarajan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oley</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Colley</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gedeon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Quinlivan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dixon</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Laing</surname>
            <given-names>NG</given-names>
          </name>
          <article-title>Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the <italic>RYR1</italic> gene</article-title>
          <source>Neuromuscul Disord</source>
          <year>2003</year>
          <volume>13</volume>
          <issue>2</issue>
          <fpage>151</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-8966(02)00218-3</pub-id>
          <pub-id pub-id-type="pmid">12565913</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kossugue</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Paim</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Navarro</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Pavanello</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Gurgel-Giannetti</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zatz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vainzof</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Central core disease due to recessive mutations in <italic>RYR1</italic> gene: is it more common than described?</article-title>
          <source>Muscle Nerve</source>
          <year>2007</year>
          <volume>35</volume>
          <issue>5</issue>
          <fpage>670</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="doi">10.1002/mus.20715</pub-id>
          <pub-id pub-id-type="pmid">17226826</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ibarra</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Malicdan</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Murayama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ichihara</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kikuchi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nonaka</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Noguchi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Nishino</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Central core disease is due to <italic>RYR1</italic> mutations in more than 90% of patients</article-title>
          <source>Brain</source>
          <year>2006</year>
          <volume>129</volume>
          <fpage>1470</fpage>
          <lpage>1480</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awl077</pub-id>
          <pub-id pub-id-type="pmid">16621918</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Treves</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Ducreux</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Divet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bleunven</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Grasso</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Paesante</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zorzato</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders</article-title>
          <source>Neuromuscul Disord</source>
          <year>2005</year>
          <volume>15</volume>
          <issue>9&#x2013;10</issue>
          <fpage>577</fpage>
          <lpage>587</lpage>
          <pub-id pub-id-type="pmid">16084090</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Monnier</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Romero</surname>
            <given-names>NB</given-names>
          </name>
          <name>
            <surname>Lerale</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Landrieu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nivoche</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fardeau</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lunardi</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <issue>22</issue>
          <fpage>2581</fpage>
          <lpage>2592</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/10.22.2581</pub-id>
          <pub-id pub-id-type="pmid">11709545</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Miller</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Dykes</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Polesky</surname>
            <given-names>HF</given-names>
          </name>
          <article-title>A simple salting out procedure for extracting DNA from human nucleated cells</article-title>
          <source>Nucleic Acids Res</source>
          <year>1988</year>
          <volume>16</volume>
          <fpage>1215</fpage>
          <pub-id pub-id-type="doi">10.1093/nar/16.3.1215</pub-id>
          <pub-id pub-id-type="pmid">3344216</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Norwood</surname>
            <given-names>FL</given-names>
          </name>
          <name>
            <surname>Harling</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chinnery</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Eagle</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bushby</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Straub</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population</article-title>
          <source>Brain</source>
          <year>2009</year>
          <volume>2009</volume>
          <issue>132</issue>
          <fpage>3175</fpage>
          <lpage>3186</lpage>
          <pub-id pub-id-type="pmid">19767415</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pandey</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chandratre</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dwyer</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Sewry</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Quinlivan</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Central core myopathy with <italic>RYR1</italic> mutation masks 5q spinal muscular atrophy</article-title>
          <source>Eur J Paediatr Neurol</source>
          <year>2011</year>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">20452790</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Quinlivan</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Laing</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Dwyer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dove</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Sewry</surname>
            <given-names>CA</given-names>
          </name>
          <article-title>Central core disease: clinical, pathological, and genetic features</article-title>
          <source>Arch Dis Child</source>
          <year>2003</year>
          <volume>88</volume>
          <issue>12</issue>
          <fpage>1051</fpage>
          <lpage>1055</lpage>
          <pub-id pub-id-type="doi">10.1136/adc.88.12.1051</pub-id>
          <pub-id pub-id-type="pmid">14670767</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Erendzhinova</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Lowry</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Lemire</surname>
            <given-names>EG</given-names>
          </name>
          <article-title>Familial RYR 1 mutation associated with mild and severe central core disease</article-title>
          <source>Can J Neurol Sci</source>
          <year>2010</year>
          <volume>37</volume>
          <issue>4</issue>
          <fpage>528</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="pmid">20724266</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Robinson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Carpenter</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Halsall</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hopkins</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Mutations in <italic>RYR1</italic> in malignant hyperthermia and central core disease</article-title>
          <source>Hum Mutat</source>
          <year>2006</year>
          <volume>27</volume>
          <issue>10</issue>
          <fpage>977</fpage>
          <lpage>989</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.20356</pub-id>
          <pub-id pub-id-type="pmid">16917943</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stark</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>O&#x2019;Donnell</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Beiswanger</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Dolan</surname>
            <given-names>ME</given-names>
          </name>
          <article-title>Population differences in the rate of proliferation of international HapMap cell lines</article-title>
          <source>Am J Hum Genet</source>
          <year>2010</year>
          <volume>87</volume>
          <issue>6</issue>
          <fpage>829</fpage>
          <lpage>833</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.10.018</pub-id>
          <pub-id pub-id-type="pmid">21109222</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Abecasis</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Altshuler</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Auton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Durbin</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Gibbs</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Hurles</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>McVean</surname>
            <given-names>GA</given-names>
          </name>
          <collab>Genomes Project C</collab>
          <article-title>A map of human genome variation from population-scale sequencing</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>467</volume>
          <issue>7319</issue>
          <fpage>1061</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="doi">10.1038/nature09534</pub-id>
          <pub-id pub-id-type="pmid">20981092</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tilgen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zorzato</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Halliger-Keller</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Muntoni</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sewry</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Palmucci</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hauser</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lehmann-Horn</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Treves</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <issue>25</issue>
          <fpage>2879</fpage>
          <lpage>2887</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/10.25.2879</pub-id>
          <pub-id pub-id-type="pmid">11741831</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
